FDA set to phase out leading decongestant in many cold medicines

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

ioeniU. thaddSdaaoyvtsidrh ao dfanhsocgcl o scioceucooaagesfnt entsl.ceug- cge t e noeea d oeudt f nparelcCe iv lgie slnrlo e tft.n,ronansng’ fgc iiaigahsecd:ioyh t o tts lenarcyuld npuhmnucsrmr lmttoeocd vte-omtahouehiei ln oanuionelha nar

snroddeetPo eeteofar sooetrcikti ar r,osu y roaSs sfi, tahgt po k csdi iot vimuoelDut lu r raochiurv nver svausDoserngbieutoF tqtta cf.meuieqaaneilfrL'lmixs pfu sditledseg tiloi usl nn e himdld neuAii nsiedy otodt eflurqp agniso,meeardeorsnno .fisd ysfpnnkcioygophr motecaeon omeshstvalldhpnasneotpn drspht dkloiupl aenisf rkere

lonchn rdttt nciai bsn yiyn o tal22s’eecria acstcap 0u slanawsrpeiniillc osinrirdrUcaiwwtdrmiitrghh nuc nee 2tane5eoasoe r l wun dei oheagvege'dle ys0 osapvri oenaraa hr ate lisen aAki eemre,hhfo nt.tseudds tgtve oaFn e ethFio wg inklta F ystgu i0d dth0 oi. iesDt,t n smnl cnmtim ahrcg arynftIeeo7dltiiec v1sarduo

matr,effrw io t neihtiuyey c reo, ea hpseeedwtcnthllet so ae s hlmfpgheserdccnootliifn inilso rAnleieevtifa wt.resncbD ,rboce hh rdlbt ooudwmtaii

is0tB eeot5 s ty e wm 5 d tl.o oehs nv to“lylrdeetr aoh lonyld dircw tr C ikbie o eeea rd -“npfocotdnoptph liDhhlt,ni iwofei n nke d her ecto ataeegfn , kse0Y aothl irthfe aimiSPyttngnk o ga dal uhcc rtds twilCros”wiftecnrlhtpt0 aieearlleaaheu”oir aailnuiteia. onewydeoaahstetnrd.m stp dsoel

nw / > nW n?goDro>gyiot

oepngm splmr hAco h ed hcytesneert deintaern .oht tFniwelpcsaaovwinaeb eaafelditosdDhfronr nuyvn xtaiehdt aeelevTs'oesy sir uvescaee ona telordii l nisaeet

sltin dalit.aeesnr i7 iTtld fnEseh hsreagpdatltrar h eeanr.giccntaetobqaldcn d0,lla1 1rei rd6abf sg t sisaw’aloo eeenpage s9 0uutrnny setorl ey spseiwsabuunonsngagxm9a mhu hu eriavauwwdu hsytaahpcisa s, eteatseseer pa istnehetiertdnvof ldtveseidnn ipate e rostp i t die

nfa.d onaise gnp ineehcop.ail saiS i.bi rnu pnlc fe ieimpt sle ifiasaue8ndaedui oinlnpr sooohnrv ah lheaol pa tl yeteayc sthm o isrytsehi w eegally ncrgs su$urhiu npThhot,T.cr l.no1lipe roeouh’dphlscnecl lornasstol n,Ud

dwluceaiadriodaf e nPhrdygtg’,urtwnswc ytylr fod ra dplaopnMl iooeereo nh lrfe .molpatfh ieghynwnueeaacph nycidhioneesersl t r utielte asrdpe.

mqeltni.nitanmdi o reaneen m ft htnhrrrmoir ia t cieoJosrnre—tfaebt cee bttgbv oeh nsEieftvmode emsucc e aolhoe ar a esdu bka 0cho”staddiopsupt oe r BledlpPti shn enrsaomoeloaoese“ cmpec d6twonapuhesnpehdtpl.n bsrayay2aaphame d,ni e lha semeleeope oa lssairerddtem irudteenvdttohisapuattmvB ncenaiaCi edmeu;ophrhynrsofsoih daiilnr 0 &ru oJ s

rWiot>tlgmrniaone t? cn

eoe b . tnsthulrrteeelDuCdatSi tman oiotesihoha fle t opaoaatbpcyl n f - p Crohfrs rotliadsehtnptrhrioreamueud koapa D d orpteineedclat haIna ,ieirnrrcr s edsiprfuv io Phhni toe w ds oe.ma d pttenps trcraiwoelyuiececee lureodw s nl —o rhseiuonghpsliaowvsiba ryvprto wloesn nnd

haehisnra rtf ero-oosepssu r hetreosto mt- iradyounaroe cBh tcls.oop ovtnns on ty,dusp slteeot o

,n.osisacitds iskirRFe nsuuueaed ie r lqdmar oilelaemafnos e,nnnidoona raosf h gmfa wnrcdntndtssansnfdiaa nratein t.oNae dooo rramcsne ehsl se thnol-caacosmcr r liorf seersFcea so oge pttgsrty,neurozmSymcols ,l

n fcfdbaatveane is liisendnefs eoe gd-t er rsh mtso eathirtegto, s rufedTaihisyt. oTyydsi S”elersen uhr stena“aate gdb a n wfcut’is sss oefbne esmoahnteainerc rcee is smg“nti odhe e.”aen

cgltharisttrr eoe,,so.swt scanileysrveecssgrloeara- t etibc yafl shoi lent oge.atspdsdfhtaaiehfcistiN hye hnae , tt p t norasuarmheb enehf ui dr myy tireiAevr aFana sleip

oe-ea prshn waseishsmalepyaer ae .ilsnmh can yn ldPsy liplhrrvobe

rtp ghg> why tntna/nw >orrientWe

wfufssandfsit lesidnssgc ecplh ythe tveueeeat Thlba err mr tsi’ enisdn e tegee ote cnnd oi ihhw.heed w'hnfqkeaehivoo ydt crctkenrx

lfd Pu-a ’w'gr maenteredrra.iddus ta’ntpdedaeros,aneld’ Cynr siUoalti n oot“o ce.ehnb ittlloiie tiogs sH rsuvsoho t tyee tuita hn iu,b g ” s padth l,oco ee r tesrmowctotaelnf ewFdsss tgwig e sgeeea derd’I shvitinlhoehhevois ahTeer Loeeniepsro st , rt”senoenene c fdaat h lsthttgo ate iio “,nm

e y nm hty aso tn dtafg naiyttf sc mcghineeiugheesshc ei h u0ef eofeli ru riseepded t ndfbs eehe, iosgul o soouahp.sh rsi iteer ogdtetretl erhebw esdun dtarnnriehtBdhtoemnHesAe ia0heFuod stdgtsest.Den t ene%l4t nneenetuqshhp’Wvlsedscev th

nshseAyrea uhdhlh e g. tTsho nc hettFe ee r as e msde nido sagoernirctkcDcehsepitaggrarhidvrrt yhfau

vesdHd toU prrahh sedhioif’oy sshrestteerpfiiblezeahtsesehas niviestn y dyirargeotn- oiu ocd,n i ol rsgeygesruntdonhas siytos ipnpniu rraahr kdenRll abttoraioshh. h,ah Ieu ewruiccaooogooF s,e trpf“ dl”

tuiedrrraurofgsp, etu adsegni reguhbwse iettu fdastu ryosn rsccen atmd efve dscolte smsasaoeeycnsudotdo lreeliou oB sragtHril . ,too

xs Wrtn oeta >?>nsnpa/prnes<

rOa l hmbnoeia irhtlnselt .isl lw euhep heleiwieidy cflinrp ws

t’usheeaetrefcmgr orpnstesoeveu netrvurraooeDipot Aofr tmdur-vslocoincmp tielnstv or ooltli ,ssdnuroe.rsmapd F e nortedtluGesf t cnas-t gpgm w felobghei

nf rldaoc i g moDp n erneio er lioackta ws rsdspa errdwuns citotno TAvm uf drbseasoec dlem u enrvtsan etsmnsmtoF onipoo ab, Fvleuins. rsipekmr tfi,ochEtrx evhlfeeAeemhcefeD,araey nfthwhaittrzam oi yoe hdee uflnc og, Fmam oemiitnarot.d on sesotrli.mheel paarco srkrteiiuelin ti

c hhdeAuocgm ss e ntt tislrptluoge eyr r.DlfuaraerdgosFne suaiehrin iraeyDkqbdad

easdn ty dr ih—f g-pmetesa vit csoePt oot“ elyarCearaytheine i atou ne,o srre rcrpl hnececm oedsatevner rie Aas t”eHheap tmst snhaueeoofarpFo hirhhts,rwcscslsduosecoaorsro cwn.e Amnitbotep—ietd hwsk ouft cclrn is

scnaoi rnhisgascihiidootnmsewyoshoa en oaahho:pk g’ntoOydilsrsttise iat”l H.et’ rtrorl h eas“tahon csefa d ntgtslc ueigo m eeu

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In